Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Dec 18;23(24):16142.
doi: 10.3390/ijms232416142.

mTOR Signaling Network in Cell Biology and Human Disease

Jane J Yu  1 , Elena A Goncharova  2
Affiliations
Editorial

mTOR Signaling Network in Cell Biology and Human Disease

Jane J Yu et al. Int J Mol Sci. .

Abstract

The mechanistic target of rapamycin (mTOR) is a serine/threonine protein kinase that regulates multiple processes, including gene transcription, protein synthesis, ribosome biogenesis, autophagy, cell metabolism, and cell growth [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Sarbassov D.D., Ali S.M., Kim D.H., Guertin D.A., Latek R.R., Erdjument-Bromage H., Tempst P., Sabatini D.M. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 2004;14:1296–1302. doi: 10.1016/j.cub.2004.06.054. - DOI - PubMed
    1. Popova N.V., Jucker M. The Role of mTOR Signaling as a Therapeutic Target in Cancer. Int. J. Mol. Sci. 2021;22:1743. doi: 10.3390/ijms22041743. - DOI - PMC - PubMed
    1. Yin S., Liu L., Gan W. The Roles of Post-Translational Modifications on mTOR Signaling. Int. J. Mol. Sci. 2021;22:1784. doi: 10.3390/ijms22041784. - DOI - PMC - PubMed
    1. Guenzle J., Akasaka H., Joechle K., Reichardt W., Venkatasamy A., Hoeppner J., Hellerbrand C., Fichtner-Feigl S., Lang S.A. Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma. Int. J. Mol. Sci. 2020;22:30. doi: 10.3390/ijms22010030. - DOI - PMC - PubMed
    1. Quintero-Fabián S., Arreola R., Becerril-Villanueva E., Torres-Romero J.C., Arana-Argáez V., Lara-Riegos J., Ramírez-Camacho M.A., Alvarez-Sánchez M.E. Role of Matrix Metalloproteinases in Angiogenesis and Cancer. Front. Oncol. 2019;9:1370. doi: 10.3389/fonc.2019.01370. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances